Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma
2021 · JAMA Surgery · 315 citations
https://doi.org/10.1001/jamasurg.2021.2373
W
Weimin Mao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
179
Papers
6.0K
Citations
32
h-index
75
i10-index
Weimin Mao is an academic researcher from Guangxi University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Esophageal Cancer Research and Treatment & Lung Cancer Diagnosis and Treatment. The author has an h-index of 32, co-authored 153 publications.
Papers by this author
worksPrognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma
2016 · Oncotarget · 106 citations
https://doi.org/10.18632/oncotarget.8956
Immunotherapy for non-small cell lung cancers: biomarkers for predicting responses and strategies to overcome resistance
2018 · BMC Cancer · 53 citations
https://doi.org/10.1186/s12885-018-4990-5
Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma
2018 · BMC Cancer · 29 citations
https://doi.org/10.1186/s12885-018-4159-2
Plasma-metabolite-based machine learning is a promising diagnostic approach for esophageal squamous cell carcinoma investigation
2020 · Journal of Pharmaceutical Analysis · 26 citations
https://doi.org/10.1016/j.jpha.2020.11.009
Drug response to HER2 gatekeeper T798M mutation in HER2-positive breast cancer
2015 · Amino Acids · 18 citations
https://doi.org/10.1007/s00726-015-2102-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat